Gats Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-11-2024
- Paid Up Capital ₹ 0.10 M
as on 04-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.90 Cr
as on 04-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 32395.42%
(FY 2023)
About Gats Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.90 Cr.
Anil Goyal, Toshit Goyal, Ghanshyam Agarwal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U33125RJ2021PTC073529
- Company No.
073529
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gats Biotech?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Goyal  | Director | 17-Feb-2021 | Current |
| Toshit Goyal | Director | 17-Feb-2021 | Current |
| Ghanshyam Agarwal | Director | 17-Feb-2021 | Current |
| Rajendra Goyal | Director | 01-Nov-2021 | Current |
| Saroj Goyal | Director | 01-Nov-2021 | Current |
| Manish Agarwal | Additional Director | 10-Feb-2024 | Current |
Financial Performance of Gats Biotech.
Gats Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gats Biotech?
Unlock access to Gats Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 May 2023 | ₹5.90 Cr | Open |
How Many Employees Work at Gats Biotech?
Gats Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gats Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gats Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
